{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T05:43:16Z","timestamp":1782020596500,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R180-2014-3606"],"award-info":[{"award-number":["R180-2014-3606"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijpharm.2018.09.070","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T02:00:46Z","timestamp":1538186446000},"page":"407-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids"],"prefix":"10.1016","volume":"552","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4715-9353","authenticated-orcid":false,"given":"Jaya","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"L\u00f6bmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-1397","authenticated-orcid":false,"given":"Holger","family":"Grohganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-6020","authenticated-orcid":false,"given":"Thomas","family":"Rades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.09.070_b0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.addr.2007.05.007","article-title":"High throughput solubility measurement in drug discovery and development","volume":"59","author":"Alsenz","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0010","first-page":"1","article-title":"Evaluation and correlation of the physicochemical properties of carvedilol","volume":"7450","author":"Alves","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0020","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/j100852a004","article-title":"Densities of Several Proteins and L-Amino Acids in the Dry State","volume":"72","author":"Berlin","year":"1968","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0025","series-title":"Biochemistry","first-page":"130","author":"Berg","year":"2002"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijpharm.2017.02.042","article-title":"Influence of preparation pathway on the glass forming ability","volume":"521","author":"Blaabjerg","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0035","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1208\/s12249-016-0616-x","article-title":"Pharmaceutical Salts of Carvedilol: Polymorphism and Physicochemical Properties","volume":"18","author":"Hiendrawan","year":"2017","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0040","unstructured":"Hildesheim, J., Finogueev, S., Aronhime, J., Dolitzky, B.-Z., Ben-Valid, S., Kor, I. United States Patent 7,056,942 B2, 06 Jun 2006."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/jphp.12458","article-title":"Preparation and characterization of spray-dried co-amorphous drug-amino acid salts","volume":"68","author":"Jensen","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/pharmaceutics6030416","article-title":"Improving co-amorphous drug formulations by the addition of the highly water soluble amino acid, Proline","volume":"6","author":"Jensen","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2016.08.022","article-title":"Development of a screening method for co-amorphous formulations of drugs and amino acids","volume":"95","author":"Kasten","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.09.063","article-title":"Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine","volume":"533","author":"Kasten","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0065","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/mp500107s","article-title":"Amino acids as Co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability","volume":"11","author":"Laitinen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2015.07.011","article-title":"Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin\u2013arginine","volume":"96","author":"Lenz","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ejpb.2013.03.014","article-title":"Amino acids as co-amorphous stabilizers for poorly water soluble drugs - part 1: preparation, stability and dissolution enhancement","volume":"85","author":"L\u00f6bmann","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules21121712","article-title":"Long-term stability of new co-amorphous drug binary systems: Study of glass transitions as a function of composition and shelf time","volume":"21","author":"Mart\u00ednez","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/pharmaceutics10020047","article-title":"Influence of solvent composition on the performance of spray-dried co-amorphous formulations","volume":"10","author":"Mishra","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.xphs.2017.09.024","article-title":"Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability","volume":"107","author":"Newman","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2010.12.035","article-title":"Carvedilol dissolution improvement by preparation of solid dispersions with porous silica","volume":"406","author":"Planin\u0161ek","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0100","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1039\/C3CE42403K","article-title":"An insight into carvedilol solid forms: effect of supramolecular interactions on the dissolution profiles","volume":"16","author":"Prado","year":"2014","journal-title":"CrystEngComm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0105","series-title":"Remington - The Science and Practice of Pharmacy","first-page":"541","article-title":"Molecular structure, properties, and states of matter","author":"Rades","year":"2013"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0110","unstructured":"Stahl, P.H., Wermuth, C.G., 2002. Handbook of Pharmaceutical Salts: Properties, Selection, and Use, in: Stahl, P.H., Wermuth, C.G. (Ed.). VHCA, Verlag Helvetica Chimica Acta, Z\u00fcrich, Switzerland, and Wiley-VCH, Weinheim, Germany."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","article-title":"Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs","volume":"12","author":"Vasconcelos","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2018.09.070_b0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2016.01.012","article-title":"Amorphous solid dispersions: Rational selection of a manufacturing process","volume":"100","author":"Vasconcelos","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ejpb.2013.09.007","article-title":"Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs","volume":"85","author":"Vo","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.09.070_b0130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.saa.2005.08.025","article-title":"Infrared spectra and molar absorption coefficients of the 20 alpha amino acids in aqueous solutions in the spectral range from 1800 to 500 cm-1","volume":"64","author":"Wolpert","year":"2006","journal-title":"Spectrochim. Acta - Part A Mol. Biomol. Spectrosc."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830735X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037851731830735X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:27:17Z","timestamp":1540268837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037851731830735X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S037851731830735X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.070","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.09.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}